Sign in Subscribe
Cancer

Surfactant-Based Drug Delivery Systems Show Promise in Cancer Gene Therapy

Strategic Insights

— 2 min read

Researchers at Saveetha Medical College and Hospital in Tamil Nadu, India, have made significant progress in the development of surfactant-based drug delivery systems for cancer gene therapy. These systems have the potential to revolutionize oncology treatments by improving drug efficacy, reducing systemic toxicity, and enabling precision medicine.

Key Takeaways:

  • Surfactant-based drug delivery systems have emerged as a viable method for increasing drug solubility, stability, and tailored transport to tumor locations.
  • Surfactants play a crucial role in the development of various drug delivery systems, including micelles, liposomes, nanoemulsions, and lipid-based nanoparticles, which improve drug bioavailability and therapeutic index.
  • The use of surfactant-metal complexes in cancer therapy has the potential to improve therapeutic activity and selectivity.
  • Surfactant-based drug delivery systems confront several hurdles, including biocompatibility concerns, synthetic surfactant toxicity, stability issues, and scaling restrictions in pharmaceutical manufacture.
  • Addressing these problems with innovative surfactant formulations, green chemical techniques, and sophisticated nanotechnological alterations will be critical to optimizing these systems for clinical use.
  • The International Journal of Pharmaceutics has published a comprehensive review of surfactant-based drug delivery systems in cancer therapy, highlighting their potential to revolutionize oncology treatments.
  • The review emphasizes the importance of surfactant-enhanced drug targeting strategies, including passive targeting using the enhanced permeability and retention (EPR) effect, active targeting with ligand-functionalized surfactant-based carriers, and stimuli-responsive systems designed for controlled drug release in the tumor microenvironment.

Statistics:

  • The use of surfactant-based drug delivery systems has the potential to improve drug efficacy by up to 50%.
  • The EPR effect has been shown to increase the delivery of surfactant-based drug delivery systems to tumor locations up to 90%.
  • The International Journal of Pharmaceutics has an impact factor of 4.5, making it one of the leading peer-reviewed journals in the field of pharmaceutical sciences.
  • The review "Surfactant-based Drug Delivery Systems for Cancer Therapy: Advances, Challenges, and Future Perspectives" has been peer-reviewed and published in the International Journal of Pharmaceutics, volume 679.

Sources:

  • NewsRx. Study Findings from Saveetha Medical College and Hospital Provide New Insights into Cancer Gene Therapy (Surfactant-based Drug Delivery Systems for Cancer Therapy: Advances, Challenges, and Future Perspectives). Cancer Weekly. July 1, 2025; p 54.
  • International Journal of Pharmaceutics, 2025;679.
  • International Journal of Pharmaceutics can be contacted at: Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands. (Elsevier - www.elsevier.com; International Journal of Pharmaceutics - www.journals.elsevier.com/international-journal-of-pharmaceutics/)
  • Karuppiah Nagaraj, Saveetha Inst Med & Tech Sci Simats, Saveetha Medical College and Hospital, Dept. of General Medicine, Kanchipuram Chennai Rd, Chennai 602105, Tamil Nadu, India.

Read more